Table 1 Participant demographics
From: Virtual reality experience in haemato-oncology patients—technical evaluation (ViREB-TE)
Participant demographics | N = 50 (%) Median (IQR) [Range] | P |
|---|---|---|
Patient | ||
All | 31 (62.0) | |
Bone Marrow Transplant | 12 (38.7) | |
Other Haematology | 17 (54.8) | |
Other illness | 2 (6.5) | |
Staff | 10 (20.0) | |
Carer/Relative/Friend | 9 (18.0) | |
Patient Primary Diagnoses | ||
Leukaemia | 15 (48.4) | |
Lymphoma | 10 (32.3) | |
Myeloma | 3 (9.7) | |
Other Haematology | 1 (3.2) | |
Other Cancer | 1 (3.2) | |
Not recorded | 1 (3.2) | |
Age (years) | 0.32 | |
All | 30.5 (25.5–43) [19–68] | |
Patient | 28 (24–39) [19–68] | |
Relative/Friend | 29 (26–42) [20–44] | |
Staff | 39.5 (31–48) [26–53] | |
Gender | 0.29 | |
Female | 27 (54.0) | |
Male | 22 (44.0) | |
Rather not Say | 1 (2.0) | |
Use of Equipment (minutes) | 0.02 | |
All | 20 (15–20) [10–60] | |
Patient | 25 (20–35) [10–60] | |
Relative/Friend | 20 (15–20) [10–25] | |
Staff | 15 (15–25) [10–30] | |
VR locations visited | ||
Unique Places | 55 | |
Australia | 13 (23.6) | |
North America | 10 (18.2) | |
Europe | 9 (16.4) | |
Asia | 8 (14.5) | |
United Kingdom | 5 (9.0) | |
Other | 10 (18.1) | |